ATE405287T1 - Diätetische ergänzung für dialyse patienten - Google Patents
Diätetische ergänzung für dialyse patientenInfo
- Publication number
- ATE405287T1 ATE405287T1 AT98914229T AT98914229T ATE405287T1 AT E405287 T1 ATE405287 T1 AT E405287T1 AT 98914229 T AT98914229 T AT 98914229T AT 98914229 T AT98914229 T AT 98914229T AT E405287 T1 ATE405287 T1 AT E405287T1
- Authority
- AT
- Austria
- Prior art keywords
- dietary supplement
- dialysis patients
- dialysis
- patient
- hypoalbuminemia
- Prior art date
Links
- 238000000502 dialysis Methods 0.000 title abstract 3
- 235000015872 dietary supplement Nutrition 0.000 title 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 abstract 1
- 208000003623 Hypoalbuminemia Diseases 0.000 abstract 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- 229930182844 L-isoleucine Natural products 0.000 abstract 1
- 235000019454 L-leucine Nutrition 0.000 abstract 1
- 239000004395 L-leucine Substances 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- 229930195722 L-methionine Natural products 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 229960002885 histidine Drugs 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 abstract 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 229960002898 threonine Drugs 0.000 abstract 1
- 229960004441 tyrosine Drugs 0.000 abstract 1
- 229960004295 valine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/000014 WO1998030217A1 (en) | 1997-01-06 | 1998-01-05 | Supplement for dialysis patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE405287T1 true ATE405287T1 (de) | 2008-09-15 |
Family
ID=22266136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98914229T ATE405287T1 (de) | 1998-01-05 | 1998-03-13 | Diätetische ergänzung für dialyse patienten |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1044017B1 (de) |
| JP (1) | JP2002500191A (de) |
| AT (1) | ATE405287T1 (de) |
| AU (1) | AU751556B2 (de) |
| CA (1) | CA2317038C (de) |
| DE (1) | DE69839922D1 (de) |
| DK (1) | DK1044017T3 (de) |
| ES (1) | ES2311297T3 (de) |
| PT (1) | PT1044017E (de) |
| TR (1) | TR200001896T2 (de) |
| WO (1) | WO1999034813A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4711523B2 (ja) * | 2001-02-13 | 2011-06-29 | 日本臓器製薬株式会社 | 低アルブミン血症改善剤 |
| US20080268038A1 (en) * | 2007-04-26 | 2008-10-30 | Wolfe Robert R | Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength |
| CN107997182A (zh) * | 2017-11-02 | 2018-05-08 | 上海市杨浦区市东医院 | 一种肾衰竭透析患者使用的固定营养剂 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3764703A (en) * | 1969-11-07 | 1973-10-09 | Astra Ab | Amino acid mixture for use in treatment of uremic conditions |
| DE2531204C2 (de) * | 1975-07-12 | 1987-01-22 | Fresenius AG, 6380 Bad Homburg | L-Aminosäuregemische für die parenterale oder orale Ernährung |
| JPS568312A (en) * | 1979-07-03 | 1981-01-28 | Otsuka Pharmaceut Factory Inc | Amino acid pharmaceutical preparation |
| JPS6217A (ja) * | 1985-02-14 | 1987-01-06 | Chugai Pharmaceut Co Ltd | 安定な活性型ビタミンd3類製剤 |
| US4752619A (en) * | 1985-12-23 | 1988-06-21 | The Johns Hopkins University | Nutritional supplement for treatment of uremia |
| ES2070994T3 (es) * | 1989-04-20 | 1995-06-16 | Zambon Spa | Profarmaco de dopamina. |
| JP2534139B2 (ja) * | 1989-10-09 | 1996-09-11 | 株式会社大塚製薬工場 | 腎不全用経口アミノ酸製剤 |
| JPH04159219A (ja) * | 1990-10-23 | 1992-06-02 | Otsuka Pharmaceut Factory Inc | 腎不全用経口アミノ酸製剤 |
| KR100309972B1 (ko) * | 1992-12-22 | 2001-12-28 | 데이비드 씨. 맥키, 토마스 제어. 시바티노 | 복막투석환자치료용의개량아미노산용액 |
| US5728678A (en) * | 1995-06-06 | 1998-03-17 | Nestec Ltd. | Method and composition for providing nutrition to a renal failure patient |
-
1998
- 1998-03-13 AT AT98914229T patent/ATE405287T1/de active
- 1998-03-13 WO PCT/US1998/003815 patent/WO1999034813A1/en not_active Ceased
- 1998-03-13 DE DE69839922T patent/DE69839922D1/de not_active Expired - Lifetime
- 1998-03-13 TR TR2000/01896T patent/TR200001896T2/xx unknown
- 1998-03-13 DK DK98914229T patent/DK1044017T3/da active
- 1998-03-13 ES ES98914229T patent/ES2311297T3/es not_active Expired - Lifetime
- 1998-03-13 CA CA002317038A patent/CA2317038C/en not_active Expired - Lifetime
- 1998-03-13 JP JP2000527261A patent/JP2002500191A/ja active Pending
- 1998-03-13 PT PT98914229T patent/PT1044017E/pt unknown
- 1998-03-13 EP EP98914229A patent/EP1044017B1/de not_active Expired - Lifetime
- 1998-03-13 AU AU68633/98A patent/AU751556B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU751556B2 (en) | 2002-08-22 |
| ES2311297T3 (es) | 2009-02-01 |
| TR200001896T2 (tr) | 2000-12-21 |
| CA2317038C (en) | 2006-10-17 |
| WO1999034813A1 (en) | 1999-07-15 |
| JP2002500191A (ja) | 2002-01-08 |
| AU6863398A (en) | 1999-07-26 |
| PT1044017E (pt) | 2008-11-03 |
| EP1044017B1 (de) | 2008-08-20 |
| EP1044017A1 (de) | 2000-10-18 |
| CA2317038A1 (en) | 1999-07-15 |
| EP1044017A4 (de) | 2005-01-05 |
| DE69839922D1 (de) | 2008-10-02 |
| DK1044017T3 (da) | 2008-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2111384T3 (es) | Composicion dietetica para adolescentes. | |
| US4491589A (en) | Amino acid solutions for parenteral nutrition and methods of formulation and use | |
| US7682625B2 (en) | Method for treating wounds to promote healing | |
| WO2005017094A3 (en) | N-acetyl compositions as adjunct therapy for treatment and prevention of cysteine/glutathione deficiency | |
| DE60336559D1 (de) | Orale vorrichtung zur aufrecherhaltung der stabilität des kausystems eines nutzers | |
| RU2009126763A (ru) | Лечение общих расстройств развития | |
| DE69839922D1 (de) | Diätetische ergänzung für dialyse patienten | |
| Waymack et al. | Nutritional support of the burned patient | |
| CN103269697A (zh) | 半胱氨酸和食物摄入 | |
| JPS568312A (en) | Amino acid pharmaceutical preparation | |
| DE602004026514D1 (de) | Orale Zusammensetzung aus Naturstoffen zum Erhalt der richtigen Hautfeuchtigkeit | |
| BR9914945A (pt) | Processo para proporcionar terapiacosmética/medicinal | |
| FR2317917A1 (fr) | Melanges de l-aminoacides et leur utilisation therapeutique | |
| Shoveller et al. | N‐acetylcysteine is a highly available precursor for cysteine in the neonatal piglet receiving parenteral nutrition | |
| BR0009875A (pt) | Uso de n-acetilcisteìna para a preparação de um medicamento adequado para a administração intravenosa para prevenir a carga oxidativa em pacientes que sofreram diálise | |
| DK1605957T3 (da) | Anvendelse af lupin-konglutin til behandling af type II-diabetes | |
| CN107854426A (zh) | 一种新型氨基酸腹膜透析液 | |
| CN101472577A (zh) | 透析患者用输液 | |
| GB1477732A (en) | Nutrient fluids | |
| JPH07285859A (ja) | 鎮痛作用増強剤 | |
| LOSS | Rajat Kandhari | |
| WO2024155260A1 (en) | A chemical compound that promotes healthy nail growth and contributes to the promotion of the hair cycle and growth and the prevention of hair loss | |
| Barber et al. | Regulation of the Urea Cycle during Lactation | |
| UA6604U (en) | Method for treating syndrome of irritated intestine | |
| Chakraborty et al. | Amino acids from marine fish and their implications in health and diseases In: Winter School on Vistas in Marine Biotechnology 5th to 26th October 2010 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1044017 Country of ref document: EP |